fda category 2 bulk drug substances bpc-157 Industry Update: Interim 503A and 503B Bulks Lists New Revisions This just in: The FDA
This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change BPC 157 Peptide Report The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. This Isn't Really About BPC 157: The Bigger Picture of the FDA's Meeting on Peptides BPC 157 FDA Approval Status 2026: Clinical Trials
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

